GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Price-to-Owner-Earnings

ACME Laboratories (DHA:ACMELAB) Price-to-Owner-Earnings : 3.01 (As of Jun. 19, 2024)


View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Price-to-Owner-Earnings?

As of today (2024-06-19), ACME Laboratories's share price is BDT64.30. ACME Laboratories's Owner Earnings per Share (TTM) ended in Mar. 2024 was BDT21.33. It's Price-to-Owner-Earnings for today is 3.01.


The historical rank and industry rank for ACME Laboratories's Price-to-Owner-Earnings or its related term are showing as below:

DHA:ACMELAB' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.89   Med: 3.43   Max: 218.64
Current: 2.98

During the past 8 years, the highest Price-to-Owner-Earnings of ACME Laboratories was 218.64. The lowest was 2.89. And the median was 3.43.


DHA:ACMELAB's Price-to-Owner-Earnings is ranked better than
96.71% of 426 companies
in the Drug Manufacturers industry
Industry Median: 24.73 vs DHA:ACMELAB: 2.98

As of today (2024-06-19), ACME Laboratories's share price is BDT64.30. ACME Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was BDT8.77. Therefore, ACME Laboratories's PE Ratio for today is 7.34.

As of today (2024-06-19), ACME Laboratories's share price is BDT64.30. ACME Laboratories's EPS without NRI for the trailing twelve months (TTM) ended in was BDT8.77. Therefore, ACME Laboratories's PE Ratio without NRI for today is 7.34.

During the past 8 years, ACME Laboratories's highest PE Ratio without NRI was 16.97. The lowest was 6.47. And the median was 9.90.


ACME Laboratories Price-to-Owner-Earnings Historical Data

The historical data trend for ACME Laboratories's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Price-to-Owner-Earnings Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - 188.35 3.79

ACME Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 3.79 3.43 3.39

Competitive Comparison of ACME Laboratories's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACME Laboratories's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where ACME Laboratories's Price-to-Owner-Earnings falls into.



ACME Laboratories Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

ACME Laboratories's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=64.30/21.33
=3.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ACME Laboratories  (DHA:ACMELAB) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


ACME Laboratories Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


ACME Laboratories (DHA:ACMELAB) Business Description

Traded in Other Exchanges
N/A
Address
1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines